Mauro Salvi

Targeting the E1 ubiquitin-activating enzyme (UBA1) improves elexacaftor/tezacaftor/ivacaftor efficacy towards F508del and rare misfolded CFTR mutants

Cellular and Molecular Life Sciences 2022cited by 21position: lastdoi

Protein kinase CK2: a potential therapeutic target for diverse human diseases

Signal Transduction and Targeted Therapy 2021cited by 383position: middledoi

Targeting CK2 in cancer: a valuable strategy or a waste of time?

Cell Death Discovery 2021cited by 42position: firstdoi

How can a traffic light properly work if it is always green? The paradox of CK2 signaling

Critical Reviews in Biochemistry and Molecular Biology 2021cited by 33position: lastdoi

Role of CK2 inhibitor CX-4945 in anti-cancer combination therapy – potential clinical relevance

Cellular Oncology 2020cited by 84position: lastdoi

“Janus” efficacy of CX-5011: CK2 inhibition and methuosis induction by independent mechanisms

Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 2020cited by 20position: lastdoi

Activity of CK2α protein kinase is required for efficient replication of some HPV types

PLoS Pathogens 2019cited by 41position: middledoi

Protein Kinase CK2 Subunits Differentially Perturb the Adhesion and Migration of GN11 Cells: A Model of Immature Migrating Neurons

International Journal of Molecular Sciences 2019cited by 39position: lastdoi

The protein kinase CK2 contributes to the malignant phenotype of cholangiocarcinoma cells

Oncogenesis 2019cited by 36position: middledoi

A Journey through the Cytoskeleton with Protein Kinase CK2

Current Protein and Peptide Science 2019cited by 30position: lastdoi

Dependence of HSP27 cellular level on protein kinase CK2 discloses novel therapeutic strategies

Biochimica et Biophysica Acta (BBA) - General Subjects 2018cited by 19position: lastdoi

Re-evaluation of protein kinase CK2 pleiotropy: new insights provided by a phosphoproteomics analysis of CK2 knockout cells

Cellular and Molecular Life Sciences 2017cited by 126position: middledoi

Generation and quantitative proteomics analysis of CK2α/α’(−/−) cells

Scientific Reports 2017cited by 50position: middledoi

Exploring the CK2 Paradox: Restless, Dangerous, Dispensable

Pharmaceuticals 2017cited by 48position: middledoi

Polo-like kinase 2 modulates α-synuclein protein levels by regulating its mRNA production

Neurobiology of Disease 2017cited by 24position: middledoi

Design, validation and efficacy of bisubstrate inhibitors specifically affecting ecto-CK2 kinase activity

Biochemical Journal 2015cited by 30position: middledoi

Quantitative analysis of a phosphoproteome readily altered by the protein kinase CK2 inhibitor quinalizarin in HEK-293T cells

Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics 2014cited by 44position: middledoi

Superiority of PLK-2 as α-synuclein phosphorylating agent relies on unique specificity determinants

Biochemical and Biophysical Research Communications 2012cited by 30position: firstdoi

Recent publications

Grants

Frequent collaborators